Blog
0
Become a Tigerlily ANGEL Advocate
0

In the U.S., breast cancer is the most commonly diagnosed cancer amongst women in their 20s and 30s, and Black women are diagnosed at younger ages and with ...

0
Recognizing Stress from Cancer and Strategies for Managing It
0

The weight of choosing the best course of a multiple myeloma treatment plan and anticipating potential relapses are significant sources of apprehension and ...

0
‘Landmark’ Findings Led to Alecensa Approval for ALK-Positive NSCLC
0

Notably, Alecensa can enter the brain, which will help any brain metastases from ALK-positive lung cancer. The approval by the Food and Drug Administration ...

0
That Cancer Conversation podcast – One to one with Dr Anisha Patel
0

Welcome to another episode of That Cancer Conversation! While bowel cancer is relatively rare for people in their 30s and 40s to get bowel cancer, cases ...

0
Extending Healing Commitment to a Cancer Community
0

From left: MEREDITH R. COOPER, M.A., CCLS, LPC, and MEAGHAN MOONEY, B.S.N., RN, OSN PHOTOS BY ZACH BRIGHAMThe initial introduction of Meaghan Mooney, ...

0
His Majesty King Charles III announced as new patron of Cancer Research UK – Cancer Research UK
0

Today it has been announced that His Majesty King Charles III will become the Patron of Cancer Research UK. “We are delighted that His Majesty King ...

0
FDA Approves Tivdak for Metastatic Cervical Cancer
0

The FDA approved Tivdak for certain patients with metastatic cervical cancer.The Food and Drug Administration (FDA) approved Tivdak (tisotumab vedotin-tftv) ...

0
When My Wait and Watch Routine for Follicular Lymphoma Ended
0

Capela dos Ossos (Chapel of Bones)Above the chapel door, a sign reads“we bones, are here, waiting for yours.”—Atlas ObscuraDuring your last autumn, we ...

0
Side Effects to Know About for Enhertu in HER2-Positive Solid Tumors
0

After the Food and Drug Administration approved Enhertu (fam-trastuzumab deruxtecan-nxki) for patients with HER2-positive solid tumors, an expert spoke with ...

0
Herceptin Biosimilar, Hercessi, Approved by FDA in Breast, Gastric Cancers
0

The Food and Drug Administration (FDA) has approved Hercessi (HLX02, trastuzumab-strf), a biosilimar to Herceptin (trastuzumab) for the adjuvant ...

0
I Don’t Have All the Cancer Answers, But I Wish I Did
0

After almost 10 years of surviving cancer, many people think I have a secret that I’m not sharing. They reach out through social media asking for my advice. ...

0
The Essence of Remarkable Cancer Care
0

The Extraordinary Healer Award for Oncology Nursing celebrates the unsung heroes in the world of cancer treatment. Oncology nurses are the unsung heroes of ...

CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart